Yissum: Technology For The Future

Are you dedicated to turning science into commercial products for everyone to benefit from? Yissum and the Hebrew University of Jerusalem is this dedicated. Over the past 40 years, Yissum has obtained over 400 technology licenses and generated almost $1 billion in sales worldwide from successful products produced by teachers and students of the Hebrew Technology Transfer University.

Yissum is the technology transfer company of the Hebrew University of Jerusalem (HU). It is responsible for marketing the inventions and know-how generated by the University's renowned researchers and students, including nanotechnology, medicine and pharmaceuticals, agriculture and nutrition, water and environmental technologies, computer science, and homeland security to name a few.

Yissum provides a range of business development services, for Hebrew University of Jerusalem inventions and technology, to inventors from conducting market research and preparing market overviews to identifying potential strategic partners and negotiating contracts.

Exelon
Exelon is a cholinesterase inhibitor. Exelon is a type of medicine prescribed for people in the early or middle stages of Alzheimer's disease. Exelon has been shown to be an effective medicine for treating the symptoms of mild to moderate Alzheimer's disease.

For great ideas produced from hard work and the smarts of teachers, students, and staff,visit the Hebrew University of Jerusalem official website and the university technology transfer company Yissum's Website.